Evaluation of the effect ofSilybum marianumextract on menopausal symptoms: A randomized, double-blind placebo-controlled trial

被引:6
|
作者
Saberi, Zohreh [1 ]
Gorji, Narjes [2 ]
Memariani, Zahra [2 ]
Moeini, Reihaneh [2 ]
Shirafkan, Hoda [3 ]
Amiri, Mania [4 ]
机构
[1] Babol Univ Med Sci, Sch Persian Med, Dept Persian Med, Babol Sar, Iran
[2] Babol Univ Med Sci, Hlth Res Inst, Tradit Med & Hist Med Sci Res Ctr, Babol Sar, Iran
[3] Babol Univ Med Sci, Hlth Res Inst, Babol Sar, Iran
[4] Babol Univ Med Sci, Infertil & Reprod Hlth Res Ctr, Hlth Res Inst & Clin Res, PCOs Clin, Babol Sar, Iran
关键词
herbal medicine; hot flashes; menopause; Milk thistle; Silybum marianum; HOT FLASHES; VASOMOTOR SYMPTOMS; SEROTONERGIC SYSTEM; EFFICACY; RELIEF; RECURRENCE; SILYMARIN; QUALITY; THERAPY; FLUSHES;
D O I
10.1002/ptr.6789
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The tendency to use herbs to manage menopausal symptoms has increased in recent years. The purpose of this study was to evaluate the effect ofSilybum marianum(L.) compared with placebo in women with hot flashes. Eighty women were randomly allocated into two equal groups (S. marianumextract [400 mg/d] or placebo capsules). Hot flashes frequency and severity were evaluated in 12 weeks with the Greene Climacteric Scale (GCS) and the Hot Flash Related Daily Interference Scale (HFRDIS). The data were analyzed in SPSS software usingt-test, Mann-Whitney, chi-square test and repeated measure analysis. Hot flashes frequency and severity decreased from 4.32 +/- 0.20/day to 1.31 +/- 0.15/day and from 5.25 +/- 0.22 to 1.62 +/- 0.08, respectively, during the study in test group (p< .001) which were significantly better than effects of placebo in all steps of study (p< .001). Significant decreases in GCS and HFRDIS scores were also detected inS. marianumgroup compared with placebo after 4, 8 and 12 weeks (p< .001). The results showed thatS. marianumcan decrease frequency and severity of hot flashes significantly. Considering the safety and high consumption of this herbal medicine worldwide, its use in women with menopausal symptoms can be helpful.
引用
收藏
页码:3359 / 3366
页数:8
相关论文
共 50 条
  • [31] Evaluation of Insomnia Symptoms in a Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial of Zuranolone in Postpartum Depression
    Deligiannidis, Kristina
    Huang, Ming-Yi
    Suthoff, Ellison
    Acaster, Sarah
    Fridman, Moshe
    Gunduz-Bruce, Handan
    Lasser, Robert
    Bonthapally, Vijayveer
    Kanes, Stephen J.
    Werneburg, Brian
    [J]. BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S91 - S91
  • [32] Flaxseed on cardiovascular disease markers in healthy menopausal women:: a randomized, double-blind, placebo-controlled trial
    Dodin, Sylvie
    Cunnane, Stephen C.
    Masse, Benoit
    Lemay, Andre
    Jacques, Helene
    Asselin, Genevieve
    Tremblay-Mercier, Jennifer
    Marc, Isabelle
    Lamarche, Benoit
    Legare, France
    Forest, Jean-Claude
    [J]. NUTRITION, 2008, 24 (01) : 23 - 30
  • [33] Efficacy of Individualized Homeopathic Medicines in the Treatment of Menopausal Syndrome: Double-Blind, Randomized, Placebo-Controlled Trial
    Ghosh, Shubhamoy
    Palanisamy, Chithra
    Das, Aakash Deep
    Mandal, Sanjukta
    Guha, Nilanjana
    Maiti, Shukdeb
    Ghosh, Priyanka
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    [J]. JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2023, 29 (10): : 649 - 664
  • [34] Evaluation of the effect of Lepidium meyenii Walpers in infertile patients: A randomized, double-blind, placebo-controlled trial
    Melnikovova, Ingrid
    Russo, Daniela
    Fait, Tomas
    Kolarova, Michaela
    Tauchen, Jan
    Kushniruk, Nataliya
    Falabella, Roberto
    Milella, Luigi
    Cusimamani, Eloy Fernandez
    [J]. PHYTOTHERAPY RESEARCH, 2021, 35 (11) : 6359 - 6368
  • [35] A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression
    Romijn, Amy R.
    Rucklidge, Julia J.
    Kuijer, Roeline G.
    Frampton, Chris
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 (08): : 810 - 821
  • [36] Risperidone Improves Behavioral Symptoms in Children with Autism in a Randomized, Double-Blind, Placebo-Controlled Trial
    Gahan J. Pandina
    Cynthia A. Bossie
    Eriene Youssef
    Young Zhu
    Fiona Dunbar
    [J]. Journal of Autism and Developmental Disorders, 2007, 37 : 367 - 373
  • [37] Randomized, double-blind, placebo-controlled trial of polyethylene glycol (MiraLAX®) for urinary urge symptoms
    Bush, Nicol Corbin
    Shah, Anjana
    Barber, Theodore
    Yang, Mary
    Bernstein, Ira
    Snodgrass, Warren
    [J]. JOURNAL OF PEDIATRIC UROLOGY, 2013, 9 (05) : 597 - 604
  • [38] A double-blind placebo-controlled trial of modafinil for negative symptoms in schizophrenia
    Pierre, JM
    Peloian, JH
    Wirshing, DA
    Wirshing, WC
    Marder, SR
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 93S - 93S
  • [39] Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial
    Pandina, Gahan J.
    Bossie, Cynthia A.
    Youssef, Eriene
    Zhu, Young
    Dunbar, Fiona
    [J]. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2007, 37 (02) : 367 - 373
  • [40] Cisapride in the control of symptoms in infants with gastroesophageal reflux: A randomized, double-blind, placebo-controlled trial
    Cohen, RC
    O'Loughlin, EV
    Davidson, GP
    Moore, DJ
    Lawrence, DM
    [J]. JOURNAL OF PEDIATRICS, 1999, 134 (03): : 287 - 292